MedTech Stocks' Q4 Earnings on Feb 22: FMS, GKOS & More

03:06pm, Tuesday, 21'st Feb 2023 Zacks Investment Research
MedTech companies' Q4 results are likely to reflect strength in customer demand. Let's see how FMS, GKOS, MMSI and DVA are placed ahead of their earnings releases.
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
I've been unfailingly bullish in the long-term on Fresenius - both the medical care, but also the main company headquartered in Germany. Fresenius has had an extremely tricky set of years, due to comp

The 9 Best 4+% Yielding Dividend Aristocrats For 2023

12:50pm, Saturday, 31'st Dec 2022 Seeking Alpha
There are no more dependable dividend growth blue-chips for the 2023 recession than dividends aristocrats. Click to read about my favorite 9 dividend stocks.
Dividend growth blue-chips are the best performing assets in history. There are no more dependable dividend growth blue-chips for the 2023 recession than dividends aristocrats.

Why Is Nevro (NVRO) Up 14.9% Since Last Earnings Report?

04:32pm, Friday, 02'nd Dec 2022 Zacks Investment Research
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

11 Black Friday Dividend Aristocrat Deals

12:02pm, Friday, 18'th Nov 2022 Seeking Alpha
Black Friday is a time to gorge on the world's best blue-chip bargains, not just left-over turkey. Read more here.

3 Stocks With Dividends of 3% or More to Buy on the Dip

02:30pm, Monday, 14'th Nov 2022 The Motley Fool
Three underpriced healthcare stocks provide an opportunity.
Three underpriced healthcare stocks provide an opportunity.
Douglas Dynamics and Fresenius Medical have been highlighted as Zacks Bull and Bear of the Day.

Bear of the Day: Fresenius Medical (FMS)

12:00pm, Friday, 11'th Nov 2022 Zacks Investment Research
Profit estimates are moving in the wrong direction.

Bear of the Day: Fresenius Medical (FMS)

08:17am, Friday, 11'th Nov 2022
Profit estimates are moving in the wrong direction.
Fresenius Medical's (FMS) third-quarter revenues benefit from strong performance across all the geographic regions and segments. However, rising costs hurt margins.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS ) Q3 2022 Earnings Conference Call October 31, 2022 10:30 AM ET Company Participants Dominik Heger - Head of Investor Relations Carla Kriwet - Chief Exec
Kidney dialysis provider Fresenius Medical Care (FMC) on Sunday revised down its forecast for 2022, expecting net income to decline this year, dragged down by rising labour costs and a slower than exp
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE